What is GLP-3 Peptide (Retatrutide)?

GLP-3, commonly referred to as Retatrutide (LY3437943), is an advanced triple agonist peptide designed to activate three important metabolic receptors at the same time: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors. Its unique tri-agonist activity positions it as a next-generation compound in metabolic and peptide research. Checkout our shop for retatrutide for sale.

Compared to single-acting or dual-agonist peptides, GLP-3 offers a broader approach for studying multiple metabolic pathways simultaneously. This makes it especially useful in research focused on energy balance, glucose regulation, and metabolic signaling processes.

Retatrutide how to get – Retatrutide cost

Retatrutide is generally accessed through a qualified healthcare provider who determines whether the treatment is suitable for the individual. The process commonly involves a medical evaluation, discussion of treatment objectives, and ongoing supervision to help manage dosage and monitor progress safely. To learn more about how to get Retatrutide and current Retatrutide pricing. Checkout our shop for retatrutide for sale.

Retatrutide is a synthetic peptide consisting of 39 amino acids and developed from a GIP-based molecular structure. The peptide contains modified amino acid residues (Aib2, Aib20, aMeL13) along with a C20 fatty diacid chain designed to enhance stability and improve albumin binding.

In research settings, Retatrutide acts as a triple receptor agonist, targeting glucagon receptors (GCGR), glucagon-like peptide-1 receptors (GLP-1R), and glucose-dependent insulinotropic polypeptide receptors (GIPR). Through this multi-receptor activity, Retatrutide has been studied for its potential influence on metabolic pathways, including energy expenditure, nutrient processing, lipid metabolism, and amino acid regulation in both cellular and animal models. Checkout our shop for retatrutide for sale.